1st ProCAncer-I Project Dissemination Event in Vienna

An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum: In Europe, prostate cancer (PC) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices lead to overdiagnosis and overtreatment, necessitating more effective tools for discriminating between aggressive and non-aggressive disease. The EU-funded ProCAncer-I project proposes to develop advanced artificial intelligence models to address unmet clinical needs: diagnosis, metastases detection and prediction of response to treatment. To achieve this, partners will generate a large interoperable repository of health images, and a scalable high-performance computing platform hosting the largest collection of PC Magnetic Resonance Images used for developing robust PC AI models. To ensure the rapid clinical implementation of the models developed, the project’s partners will robustly monitor performance, accuracy and reproducibility. 

Welcome by Coordinating Team

We are very glad to lead a very ambitious and health-driven project that could end to alleviating and helping thousands of men to tackle prostate cancer in a more personalized way supporting a better quality of life

The Coordinating Team

Manolis Tsiknakis

Prof. Manolis Tsiknakis
(Coordinator)

Dr. Nikolaos Papanikolaou
(Scientific Manager)

Prof. Kostas Marias
(Technical Manager)

Prof. Daniele Regge
(Clinical Manager)

The ProCAncer-I project is one of the founding projects of the FUTURE-AI.

FUTURE-AI is an international, multi-stakeholder initiative for defining and maintaining concrete guidelines that will facilitate the design, development, validation, and deployment of trustworthy AI solutions in medical imaging based on six guiding principles: Fairness, Universality, Traceability, Usability, Robustness, and Explainability.

Project Information

Months (Duration)

Euros (Total Budget )

Grant Agreement Nr.

Funded

This project has received funding from the European Union’s Horizon 2020 research and innovation programme

|

Topic

DT-TDS-05-2020:
AI for Health Imaging

Highlights

"The Commission also commits to supporting research on cancer screening, strengthening cooperation between EU Member States and overcoming legal and technical barriers to data sharing to support screening" https://uroweb.org/news/life-changing-recommendations-by-european-commission-for-men-impacted-by-prostate-cancer

@EuCanImage together with other AI4HI projects organised a workshop within the IEEE BHI-BHS Conference today in Ioannina. What a great way to showcase AI4HI network initiative & advances. @chaimeleon_eu @IncisiveEu @primage_project @ProCAncer_I

24th of September is celebrated as World Cancer Research Day. #Cancer research has had major impact on improving cancer survival rates and better quality of life of patients. Bravo to our researchers!
#worldcancerresearchday #cancerresearch #wcrd2022 #healthcare #HealthIT #H2020

📢 Job Alert!
#Candiolo_Cancer_Institute is currently looking for a Radiologist and a Research Assistant!
Read more here 👉 https://www.procancer-i.eu/get-involved/job-openings/
.
.
.
#JobAlert #radiologist #researchassistan #research #sciencecareers #careers #H2020 #HorizonEU #EU_HEALTH

📢 7 days left for the #workshop at the IEEE BHI-BSN Conference 2022 in #Ioannina!
Read more 👉 https://bit.ly/3OVF21y
.
.
.
#radiology #imaging #medicalimaging #AI, #healthcare #technology #H2020 #prostatecancer #workshop

Load More...

Stay in touch!